Related Experiment Videos
Using an in vivo phagemid system to identify non-compatible loxP sequences
R W Siegel1, R Jain, A Bradbury
1Bioscience Division, Los Alamos National Laboratory, NM 87545, USA.
FEBS Letters
|June 22, 2001
Summary
The Cre/loxP system for genome manipulation is expanded by new heterologous loxP sites. However, this study found many pairs recombine unintentionally, limiting their use in genetic engineering.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- The Cre/loxP site-specific recombination system is crucial for manipulating eukaryotic genomes.
- Expanding the utility of this system requires developing heterologous loxP sequences.
- Compatibility between different loxP variants is essential for precise genome engineering.
Purpose of the Study:
- To rigorously assess the recombination compatibility between all previously reported heterologous loxP sequences.
- To determine the recombination rates for various combinations of heterologous loxP sites.
- To identify compatible and incompatible loxP pairs for improved vector design.
Main Methods:
- Development of a stringent in vivo assay to quantify recombination.
- Systematic testing of all pairwise combinations of published heterologous loxP sequences.
- Cre-mediated recombination assays in a relevant biological system.
Main Results:
- Homologous loxP sequences showed efficient Cre-mediated recombination as expected.
- A significant number of heterologous loxP pairs exhibited unintended recombination, with rates ranging from 5% to 100%.
- Previously reported non-compatible loxP pairs were confirmed, and new incompatible combinations were identified.
Conclusions:
- Not all heterologous loxP sequences are compatible, posing challenges for multiplexed genome engineering.
- The study provides critical data on loxP sequence compatibility, informing the design of new recombination vectors.
- Careful selection of loxP variants is necessary to avoid off-target recombination in Cre/loxP applications.